QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
1-Year Return
19.13%
This Quarter Return
+6.62%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$1.44B
AUM Growth
+$92.7M
(+6.9%)
Cap. Flow
+$18.1M
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
36.48%
Holding
2,823
New
124
Increased
1,022
Reduced
1,034
Closed
90
Top Buys
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
$8.33M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$4.8M |
| 3 |
Procter & Gamble
PG
|
$1.93M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$1.11M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
$954K |
Top Sells
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
$3.07M |
| 2 |
Royal Bank of Canada
RY
|
$791K |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$421K |
| 4 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
$408K |
| 5 |
NVIDIA
NVDA
|
$386K |
Sector Composition
| 1 | Technology | 16.46% |
| 2 | Financials | 8.14% |
| 3 | Healthcare | 6.83% |
| 4 | Consumer Staples | 6.07% |
| 5 | Consumer Discretionary | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
SI-BONE Inc
SIBN
$703M
| $2.31K | ﹤0.01% |
165
| – | – |
|
2477
FVCBankcorp
FVCB
$241M
| $2.3K | ﹤0.01% |
176
| – | – |
|
|
NLOP
2478
Net Lease Office Properties
NLOP
$435M
| $2.3K | ﹤0.01% |
75
+22
| +42% | +$674 |
|
2479
ACV Auctions
ACVA
$2.03B
| $2.26K | ﹤0.01% |
111
+1
| +0.9% | +$20 |
|
2480
NCR Voyix
VYX
$1.84B
| $2.25K | ﹤0.01% |
166
+154
| +1,283% | +$2.09K |
|
|
RVNC
2481
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.25K | ﹤0.01% |
+434
| New | +$2.25K |
|
2482
Sezzle
SEZL
$2.92B
| $2.22K | ﹤0.01% |
+78
| New | +$2.22K |
|
2483
Anywhere Real Estate
HOUS
$724M
| $2.21K | ﹤0.01% |
434
-94
| -18% | -$478 |
|
2484
Leslie's
LESL
$64.6M
| $2.17K | ﹤0.01% |
+686
| New | +$2.17K |
|
2485
Horace Mann Educators
HMN
$1.88B
| $2.17K | ﹤0.01% |
62
| – | – |
|
2486
AvidXchange
AVDX
$2.06B
| $2.17K | ﹤0.01% |
267
-698
| -72% | -$5.66K |
|
2487
Impinj
PI
$5.56B
| $2.17K | ﹤0.01% |
+10
| New | +$2.17K |
|
2488
Lexicon Pharmaceuticals
LXRX
$396M
| $2.15K | ﹤0.01% |
1,371
| – | – |
|
2489
Allogene Therapeutics
ALLO
$255M
| $2.13K | ﹤0.01% |
+760
| New | +$2.13K |
|
2490
Verint Systems
VRNT
$1.23B
| $2.13K | ﹤0.01% |
84
-287
| -77% | -$7.27K |
|
2491
Ryanair
RYAAY
$32.1B
| $2.12K | ﹤0.01% |
+47
| New | +$2.12K |
|
2492
Establishment Labs
ESTA
$1.13B
| $2.12K | ﹤0.01% |
49
| – | – |
|
2493
Distribution Solutions Group
DSGR
$1.48B
| $2.08K | ﹤0.01% |
54
| – | – |
|
2494
Arcus Biosciences
RCUS
$1.3B
| $2.07K | ﹤0.01% |
135
-13
| -9% | -$199 |
|
2495
Credo Technology Group
CRDO
$24.4B
| $2.06K | ﹤0.01% |
+67
| New | +$2.06K |
|
2496
PubMatic
PUBM
$383M
| $2.05K | ﹤0.01% |
138
+79
| +134% | +$1.18K |
|
2497
Biohaven
BHVN
$1.68B
| $2.05K | ﹤0.01% |
41
-1
| -2% | -$50 |
|
2498
Cass Information Systems
CASS
$569M
| $2.03K | ﹤0.01% |
49
| – | – |
|
2499
Navitas Semiconductor
NVTS
$1.19B
| $2.02K | ﹤0.01% |
+826
| New | +$2.02K |
|
2500
Birkenstock
BIRK
$9.23B
| $2.02K | ﹤0.01% |
+41
| New | +$2.02K |
|